3D bioprinting for drug discovery and development in pharmaceutics

Keyphrases

• Bioprinting 100%
• Drug Development 100%
• Drug Discovery 100%
• Pharmaceutics 100%
• 3D Bioprinting 100%
• Three Dimensional Model 30%
• Pharmaceutical Study 30%
• Fabrication Methods 20%
• Two Dimensional Model 20%
• In Vitro-in Vivo Correlation (IVIVC) 20%
• Pharmaceutical Development 20%
• Drug Delivery 10%
• Clinical Trials 10%
• Recent Advances 10%
• Full Potential 10%
• Bioink 10%
• Comparative Analysis 10%
• Financial Resources 10%
• Reliability Prediction 10%
• Extrusion 10%
• Decision Basis 10%
• High-throughput Screening 10%
• Informed Decision-making 10%
• Catastrophic Failure 10%
• Regenerative Medicine 10%
• Tissue Engineering 10%
• Analysis of Similarity (ANOSIM) 10%
• Commercial Drugs 10%
• Drug Screening 10%
• Animal Testing 10%
• Biomimetic 10%
• Difference Analysis 10%
• Toxicology 10%
• Time Resources 10%
• Computational Advance 10%
• Native Tissue 10%
• Comparative Literature 10%
• Development Cycle 10%
• Tissue Model 10%
• Living Tissue 10%
• Tissue Architecture 10%
• Drug pipeline 10%
• Tissue Constructs 10%
• Drug Discovery Research 10%
• Chemical Attributes 10%
• Limited Availability 10%
• Heterogeneous Composition 10%
• Toxicological Testing 10%
• Efficacy Testing 10%
• Spatial Attributes 10%
• Screening Drugs 10%
• Efficacy Prediction 10%
• Regenerative Tissue 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Drug Discovery 100%
• Drug Development 100%
• Pharmaceutics 100%
• Clinical Trial 25%
• High-Throughput Screening 25%
• Drug Screening 25%
• Animal Testing 25%
• Toxicology Testing 25%

Material Science

• 3D Bioprinting 100%